Contribution of endogenous opioids and nitric oxide to papillary muscle contractile impairment in cholestatic rats

European Journal of Pharmacology

Volumn 523, Issue 1-3, 2005, Pages 93-100

  Ebrahimi, Farzad ^a   Tavakoli, Sina ^a   Hajrasouliha, Amir Reza ^a   Shafaroodi, Hamed ^b   Sadeghipour, Hamed ^a   Riazi, Kiarash ^a   Borhani, Amir Ali ^a   Houshmand, Golbahar ^a   Ahmadi, Seyed Hossein ^c   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adrenoceptor; Cardiomyopathy; Cholestasis; Endogenous opioid peptide; NO (Nitric oxide); Papillary muscle

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; ENDORPHIN; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NALTREXONE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; DRUG EFFECT; HEART PAPILLARY MUSCLE; MALE; MUSCLE CONTRACTILITY; MUSCLE FORCE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC BETA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; BILE DUCTS; CARDIOMYOPATHIES; CHOLESTASIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ISOPROTERENOL; LIGATION; MALE; MYOCARDIAL CONTRACTION; NALTREXONE; NARCOTIC ANTAGONISTS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OPIOID PEPTIDES; PAPILLARY MUSCLES; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27644546792     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.08.057     Document Type: Article

References (33)

1. O.S. Better Renal and cardiovascular dysfunction in liver disease Kidney Int. 29 1986 598 607
2. O.S. Better, and A. Bomzon Effect of jaundice on the renal and cardiovascular systems M.D. Williams Wilkins. M. Epstein The Kidney in Liver Disease 3rd ed. 1998 508 534 Baltimore
3. O. Binah, A. Bomzon, L.M. Blendis, D. Mordohovich, and O.S. Better Obstructive jaundice blunts myocardial contractile response to isoprenaline in the dog: a clue to the susceptibility of jaundiced patients to shock? Clin. Sci. (Lond) 69 1985 647 653
4. O. Binah, I. Rubinstein, A. Bomzon, and O.S. Better Effects of bile acids on ventricular muscle contraction and electrophysiological properties: studies in rat papillary muscle and isolated ventricular myocytes Naunyn-Schmiedeberg's Arch. Pharmacol. 335 1987 160 165
5. A. Bomzon Cardiovascular function in obstructive jaundice: experimental observation Isr. J. Med. Sci. 22 1986 81 84
6. H.C. Champion, and P.J. Kadowitz A-[Ala2] endomorphin 2 and endomorphin 2 have nitric oxide-dependent vasodilator activity in rats Am. J. Physiol. 74 1998 H1690 H1697
7. S. Chowdhary, G.A. Ng, S.L. Nuttall, J.H. Coote, H.F. Ross, and J.N. Townend Nitric oxide and cardiac parasympathetic control in human heart failure Clin. Sci. (Lond) 102 2002 397 402
8. A.R. Dehpour, F. Meysami, N. Ebrahimi-Daryani, and N. Akbarloo Inhibition by lithium of opioid withdrawal-like syndrome and physical dependency in a model of acute cholestasis in mice Hum. Psychopharmacol. Clin. Exp. 13 1998 407 412
9. A.R. Dehpour, H. Rastegar, M. Jorjani, F. Roushanzamir, K. Joharchi, and A. Ahmadiani Subsensitivity to opioids is receptor specific in isolated guinea pig ileum and mouse vas deferens after obstructive cholestasis J. Pharmacol. Exp. Ther. 293 2000 946 951
10. A.R. Dehpour, H.R. Sadeghipour, N. Nowroozi, and N. Akbarloo The effect of serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis Hum. Psychopharmacol. Clin. Exp. 15 2000 423 428
11. S.A. Gaskari, A.R. Mani, S. Ejtemaei-Mehr, K. Namiranian, H. Homayoun, H. Ahmadi, and A.R. Dehpour Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis? Fund. Clin. Pharmacol. 16 2002 273 279
12. P. Ghafourifar, A.R. Dehpour, and N. Akbarloo Inhibition by L-NA, a nitric oxide synthase inhibitor, of naloxone-precipitated withdrawal signs in a mouse model of cholestasis Life Sci. 60 1997 265 270
13. J. Green, and O.S. Better Circulatory disturbance and renal dysfunction in liver disease and in obstructive jaundice Isr. J. Med. Sci. 30 1994 48 65
14. J. Green, R. Beyar, S. Sideman, D. Mordechovitz, and O.S. Better The jaundiced heart: a possible explanation for postoperative shock in obstructive jaundice Surgery 100 1986 14 20
15. A.R. Hajrasouliha, S. Tavakoli, P. Jabehdar-Maralani, H. Shafaroodi, A.A. Borhani, G. Houshmand, H. Sadeghipour, M. Dehghani, and A.R. Dehpour Resistance of cholestatic rats against epinephrine-induced arrhythmia: the role of nitric oxide and endogenous opioids Eur. J. Pharmacol. 499 2004 307 313
16. Heidenreich, S.E. Brinkema, A. Martin, R. Dusing, J. Kipnowski, and H.J. Kramer The kidney and cardiovascular system in obstructive jaundice: functional and metabolic studies in conscious rats Clin. Sci. (Lond) 73 1987 593 599
17. G. Jacob, N. Nassar, G. Hayam, S. Ben-Haim, Y. Edoute, O.S. Better, and A. Bomzon Cardiac function and responsiveness to β-adrenoceptor agonists in rats with obstructive jaundice Am. J. Physiol. 265 1993 G314 G320
18. H. Liu, Z. Ma, and S. Lee Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats Gastroenterology 118 2000 937 944
19. D. Lumlertgul, S. Boonyaprapa, D. Bunnachak, N. Thanachaikun, O.A. Praisontarangkul, K. Phornphutkul, and M. Keoplung The jaundiced heart: evidence of blunted response to positive inotropic stimulation Ren. Fail. 13 1991 15 22
20. A.R. Mani, A. Nahavandi, M. Moosavi, R. Safarinejad, and A.R. Dehpour Dual nitric oxide mechanisms of cholestasis-induced bradycardia in the rat Clin. Exp. Pharmacol. Physiol. 29 2002 905 908
21. P.B. Massion, O. Feron, J. Dessy, and L. Balligand Nitric oxide and cardiac function ten years after, and continuing Circ. Res. 93 2003 388 398
22. L. Moezi, M. Rezayat, M. Samini, H. Shafaroodi, S.E. Mehr, M.R. Ebrahimkhani, and A.R. Dehpour Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide Eur. J. Pharmacol. 486 2004 53 59
23. A. Nahavandi, A.R. Dehpour, A.R. Mani, H. Homayounfar, A. Abdoli, and M.R. Abdolhoseini The role of nitric oxide in bradycardia of rats with obstructive cholestasis Eur. J. Pharmacol. 411 2001 135 141
24. K. Namiranian, M. Samini, S. Ejtemaei Mehr, S.A. Gaskari, H. Rastegar, H. Homayoun, and A.R. Dehpour Mesenteric vascular bed responsiveness in bile duct-ligated rats: roles of opioid and nitric oxide systems Eur. J. Pharmacol. 423 2001 185 193
25. J.F. Paton, S. Kasparov, and D.J. Paterson Nitric oxide and autonomic control of heart rate: a question of specificity Trends Neurosci. 25 2002 626 631
26. M.K. Pugsley The diverse molecular mechanisms responsible for the actions of opioids on the cardiovascular system Pharmacol. Ther. 93 2002 51 75
27. J.C. Schadt Sympathetic and hemodynamic adjustments to hemorrhage: a possible role for endogenous opioid peptides Resuscitation 18 1989 219 228
28. T. Skomedal, J.B. Osnes, and I. Oye Differences between α-adrenergic and β-adrenergic inotropic effects in rat heart papillary muscles Acta Pharm. Toxicol. 50 1982 1 12
29. M.G. Swain, R.B. Rothman, H. XU, J. Vergalla, N.V. Bergasa, and E.A. Jones Endogenous opioids accumulate in plasma in a rat model of acute cholestasis Gastroenterology 103 1992 630 635
30. B. Szabo, T. Wichmann, and K. Starke Presynaptic opioid receptors in portal vein of the rabbit Eur. J. Pharmacol. 39 1987 103 110
31. M. Tajuddin, A. Bomzon, A. Weinbroum, and L. Kamenetz Systemic hypotension and pressor responsiveness in cholestasis: a study in conscious 3-day bile duct ligated rats J. Hepatol. 11 1990 70 76
32. J.R. Thornton, and M.S. Losowsky Plasma methionine enkephalin concentration and prognosis in primary biliary cirrhosis Br. Med. J. 297 1988 1241 1243
33. J.R. Thornton, and M.S. Losowsky Opioid peptides and primary biliary cirrhosis Br. Med. J. 297 1988 1501 1504